Ddx17 Mitigates Sepsis‐Induced Cardiomyopathy by Regulating Mitochondrial Dynamics in Cardiomyocytes
Ddx17 mildert sepsisinduzierte Kardiomyopathie durch Regulation der mitochondrialen Dynamik in Kardiomyozyten
Clinical and Experimental Pharmacology and Physiology · 2026-02 · 53 (2)
DOI: 10.1111/1440-1681.70105 ↗Auf einen Blick
In Maus- und Zellmodellen der sepsisinduzierten Kardiomyopathie war Ddx17 vermindert. Eine Überexpression verbesserte mitochondriale Parameter, senkte oxidativen Stress und apoptosisbezogene Schäden und verbesserte die Herzfunktion.
Fragestellung
Welche Rolle spielt Ddx17 bei der sepsisinduzierten Kardiomyopathie?
Methode
Mausmodell mit kardiomyozytenspezifischem Ddx17-Knockdown und -Überexpression; Sepsisinduktion durch cecal ligation and puncture; ergänzende In-vitro-Validierung mit Immunpräzipitation und Dual-Luziferase-Assays.
Ergebnisse
Ddx17 war in Herzgewebe septischer Mäuse und in LPS-behandelten Kardiomyozyten reduziert. Knockdown erhöhte mitochondriale ROS, Zelltod und senkte die Superoxiddismutase-Aktivität; Überexpression verbesserte ATP, Membranpotenzial und Herzfunktion.
Schlussfolgerung der Autor:innen
Die Autor:innen zeigen, dass Ddx17 vor sepsisinduzierter Kardiomyopathie schützt, indem es die mitochondriale Dynamik reguliert, oxidativen Stress reduziert und Apoptose verhindert.
Kernaussagen
- Ddx17 war in septischem Herzgewebe und LPS-behandelten Kardiomyozyten vermindert.
- Überexpression verbesserte ATP, Membranpotenzial und Herzfunktion im Mausmodell.
- Mechanismus: Interaktion mit STAT3 und Regulation von DRP1 und MFN1.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 08.02.2026. Verfasst von Ya-Ting Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Ningbo No. 2 Hospital, Ningbo, China. Hauptthemen laut MEDLINE: Sepsis, Myocytes, Cardiac, Mitochondrial Dynamics, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang Province, Wenzhou Municipal Science and Technology Bureau.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐induced cardiomyopathy (SICM) is a severe complication of sepsis, in which mitochondrial dysfunction contributes to poor outcomes. DEAD‐box helicase 17 (Ddx17), a member of the DEAD‐box RNA helicase family, is known to regulate mitochondrial function, but its role in SICM remains unclear. In this study, mice with cardiomyocyte‐specific Ddx17 knockdown (Ddx17‐cKD) and overexpression (Ddx17‐OE) were generated, and sepsis models were established using cecal ligation and puncture. Mechanistic findings were further validated in vitro using immunoprecipitation and dual‐luciferase assays. Ddx17 expression was markedly reduced in the cardiac tissues of septic mice and in lipopolysaccharide‐treated cardiomyocytes. Knockdown of Ddx17 increased mitochondrial reactive oxygen species accumulation, enhanced cell death and decreased superoxide dismutase activity. In contrast, Ddx17 overexpression attenuated mitochondrial apoptosis and oxidative stress, restored adenosine triphosphate production and mitochondrial membrane potential and improved cardiac function in septic mice. Mechanistically, Ddx17 interacted with signal transducer and activator of transcription 3 (STAT3) to suppress transcription of the mitochondrial fission protein dynamin‐related protein 1 while maintaining the level of the fusion protein mitofusin 1, thereby preserving mitochondrial integrity and cardiomyocyte homeostasis. These findings demonstrate that Ddx17 protects against sepsis‐induced cardiomyopathy by regulating mitochondrial dynamics, reducing oxidative stress and preventing apoptosis, thereby highlighting Ddx17 as a potential therapeutic target for septic cardiac dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency Department, Ningbo No. 2 Hospital, Ningbo, China.
- Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Key Laboratory…
- Department of Critical Care Medicine, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.
- Department of Pharmacy, Taizhou Maternal and Child Health Hospital, Taizhou, Zhejiang, China.
- Department of Anesthesiology, Xiangshan Hospital of Wenzhou Medical University, Ningbo, Zhejiang, China.
ORCID-Profile: Ya-Ting Jiang, Chen-Xi Shen
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
- Wenzhou Municipal Science and Technology Bureau
- Science and Technology Bureau of Taizhou
- Taizhou Municipal Science and Technology Bureau
Zitieren
APA
Jiang, Y. T., Su, L. R., Ni, F. J., Lu, L. Y., Gong, Y. Q., Luo, J., Shen, C. X., & Cao, Y. (2026). Ddx17 Mitigates Sepsis‐Induced Cardiomyopathy by Regulating Mitochondrial Dynamics in Cardiomyocytes. Clinical and Experimental Pharmacology and Physiology, 53(2). https://doi.org/10.1111/1440-1681.70105
Vancouver
Jiang YT, Su LR, Ni FJ, Lu LY, Gong YQ, Luo J, et al. Ddx17 Mitigates Sepsis‐Induced Cardiomyopathy by Regulating Mitochondrial Dynamics in Cardiomyocytes. Clinical and Experimental Pharmacology and Physiology. 2026;53(2). doi:10.1111/1440-1681.70105
BibTeX
@article{Jiang2026,
author = {Jiang, Ya-Ting and Su, Li-Ran and Ni, Fang-Jing and Lu, Luo-Ye and Gong, Yu-Qiang and Luo, Jun and Shen, Chen-Xi and Cao, Yang},
title = {Ddx17 Mitigates Sepsis‐Induced Cardiomyopathy by Regulating Mitochondrial Dynamics in Cardiomyocytes},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2026},
volume = {53},
number = {2},
doi = {10.1111/1440-1681.70105}
}
EUVIMED